Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$31.78 USD
0.00 (0.00%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $31.80 +0.02 (0.06%) 6:48 PM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 1.45 |
EPS Last Quarter | 1.45 |
Last EPS Surprise | -2.68% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 6.12 |
Next Year | 6.79 |
EPS (TTM) | 5.63 |
P/E (F1) | 5.19 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 142.65M | 144.65M | 582.88M | 597.26M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 144.80M | 146.93M | 590.18M | 619.00M |
Low Estimate | 140.82M | 143.48M | 580.50M | 579.60M |
Year ago Sales | 135.55M | 136.71M | 566.77M | 582.88M |
Year over Year Growth Est. | 5.23% | 5.81% | 2.84% | 2.47% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.45 | 1.54 | 6.12 | 6.79 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | 1.49 | 1.65 | 6.47 | 7.26 |
High Estimate | 1.52 | 1.65 | 6.47 | 7.36 |
Low Estimate | 1.38 | 1.39 | 5.66 | 6.00 |
Year ago EPS | 1.26 | 1.34 | 5.47 | 6.12 |
Year over Year Growth Est. | 15.08% | 14.93% | 11.88% | 10.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.45 | 1.54 | 6.12 | 6.79 |
7 Days Ago | 1.45 | 1.54 | 6.12 | 6.79 |
30 Days Ago | 1.45 | 1.54 | 6.12 | 6.79 |
60 Days Ago | 1.46 | 1.54 | 6.21 | 6.82 |
90 Days Ago | 1.44 | 1.49 | 6.16 | 6.76 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.45 | 1.54 | 6.12 | 6.79 |
Zacks Consensus Estimate | 1.45 | 1.54 | 6.12 | 6.79 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.45 | 1.58 | 1.34 | 1.26 | NA |
Estimate | 1.49 | 1.33 | 1.24 | 1.22 | NA |
Difference | -0.04 | 0.25 | 0.10 | 0.04 | 0.09 |
Surprise | -2.68% | 18.80% | 8.06% | 3.28% | 6.87% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more